Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure

Abstract

Glioblastoma multiforme (GBM) is an incurable malignant brain tumor, usually fatal within 1 year of diagnosis. Using a syngeneic rat 9L gliosarcoma model, we have developed a novel drug delivery method in which naked plasmid DNA is selectively targeted to brain tumors via intra-arterial injection. Using a plasmid encoding the antiangiogenic endostatin, transgene expression can be detected in tumor cells in vivo, and therapeutic efficacy is observed. Administration of this plasmid resulted in an 80% tumor volume reduction 1 week after treatment and enhanced survival time by up to 47%. Treated tumors exhibited a 40% decrease in the number of tumor vessels; ultrastructural analysis of remaining tumor vessels demonstrated a number of changes including markedly narrowed or collapsed lumens. We conclude that intra-arterial injection of plasmids selectively targets therapeutic genes to CNS neoplasms. This method of gene therapy holds promise for the treatment of these highly malignant brain tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Kramm CM et al. Gene therapy for brain tumors. Brain Pathol 1995; 5: 345–381.

    Article  CAS  Google Scholar 

  2. Lam PY, Breakefield XO . Potential of gene therapy for brain tumors. Hum Mol Genet 2001; 10: 777–787.

    Article  CAS  Google Scholar 

  3. Boehm T, Folkman J, Browder T, O'Reilly MS . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404–407.

    Article  CAS  Google Scholar 

  4. Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.

    Article  CAS  Google Scholar 

  5. Carmeliet P, Jain RK . Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257.

    Article  CAS  Google Scholar 

  6. O'Reilly MS et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277–285.

    Article  CAS  Google Scholar 

  7. Blezinger P et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999; 17: 343–348.

    Article  CAS  Google Scholar 

  8. Chen QR, Kumar D, Stass SA, Mixson AJ . Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Research 1999; 59: 3308–3312.

    CAS  PubMed  Google Scholar 

  9. Read TA et al. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 2001; 19: 29–34.

    Article  CAS  Google Scholar 

  10. Barnett FH et al. Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7. Cancer Gene Ther 1999; 6: 14–20.

    Article  CAS  Google Scholar 

  11. Rainov NG et al. Intra-arterial virus and nonvirus vector-mediated gene transfer to experimental rat brain tumors. Front Radiat Ther Oncol 1999; 33: 227–240.

    Article  CAS  Google Scholar 

  12. Rainov NG et al. Intraarterial delivery of adenovirus vectors and liposome–DNA complexes to experimental brain neoplasms. Hum Gene Ther 1999; 10: 311–318.

    Article  CAS  Google Scholar 

  13. Kuo CJ et al. Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J Cell Biol 2001; 152: 1233–1246.

    Article  CAS  Google Scholar 

  14. Musso O et al. Tumor hepatocytes and basement membrane-producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers. Hepatology 2001; 33: 868–876.

    Article  CAS  Google Scholar 

  15. Sauter BV et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 2000; 97: 4802–4807.

    Article  CAS  Google Scholar 

  16. Kroll RA et al. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood–brain and/or blood–tumor barriers. Neurosurgery 1998; 43: 879–886; discussion 886–879.

    Article  CAS  Google Scholar 

  17. Rainov NG et al. Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 1995; 6: 1543–1552.

    Article  CAS  Google Scholar 

  18. Loser P et al. Advances in the development of non-human viral DNA-vectors for gene delivery. Curr Gene Ther 2002; 2: 161–171.

    Article  CAS  Google Scholar 

  19. Bloch W et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J 2000; 14: 2373–2376.

    Article  CAS  Google Scholar 

  20. Zagzag D et al. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Labor Invest 2000; 80: 837–849.

    Article  CAS  Google Scholar 

  21. Holash J, Wiegand SJ, Yancopoulos GD . New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18: 5356–5362.

    Article  CAS  Google Scholar 

  22. Chan PT, Weller RO . Factors influencing tumour cell and vascular proliferation in glioblastoma. Neuropathol Appl Neurobiol 2002; 28: 155–156.

    Article  Google Scholar 

  23. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997; 3: 1354–1361.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants to MF from the National Eye Institute R24EY14174 and the Robert Mealey Program for the Study of Macular Degenerations. FB is a Skaggs Scholar in Clinical Science and receives grant support from the Skaggs Program. We are grateful to numerous members of the Friedlander Laboratory for assistance in various aspects of this project and to the staff and veterinarians of the LARC at TSRI for their excellent assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnett, F., Scharer-Schuksz, M., Wood, M. et al. Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure. Gene Ther 11, 1283–1289 (2004). https://doi.org/10.1038/sj.gt.3302287

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302287

Keywords

This article is cited by

Search

Quick links